Quest Diagnostics to Speak at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Quest Diagnostics to Speak at the 44th Annual J.P. Morgan Healthcare Conference
Quest Diagnostics Stock: Is DGX Outperforming the Healthcare Sector? [Yahoo! Finance]
Rare Disease Genetic Testing Market to Reach USD 3.79 Billion by 2032 | Growth is Driven by Rising Demand for Early Diagnostic Solutions Globally – SNS Insider [Yahoo! Finance]
Octave Bioscience Forms Strategic Collaboration with Quest Diagnostics to Expand Patient Access to the Octave® Multiple Sclerosis Disease Activity (MSDA) Test Across the United States [Yahoo! Finance]